- Home
- TKR vs BPMC Comparison
TKR vs BPMC Comparison
Compare TKR & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKR
- BPMC
- Stock Information
- Founded
- TKR 1899
- BPMC 2008
- Country
- TKR United States
- BPMC United States
- Employees
- TKR N/A
- BPMC N/A
- Industry
- TKR Metal Fabrications
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- TKR Industrials
- BPMC Health Care
- Exchange
- TKR Nasdaq
- BPMC Nasdaq
- Market Cap
- TKR 5.1B
- BPMC 5.8B
- IPO Year
- TKR N/A
- BPMC 2015
- Fundamental
- Price
- TKR $76.78
- BPMC $128.24
- Analyst Decision
- TKR Buy
- BPMC Buy
- Analyst Count
- TKR 11
- BPMC 20
- Target Price
- TKR $78.56
- BPMC $127.82
- AVG Volume (30 Days)
- TKR 553.4K
- BPMC 3.9M
- Earning Date
- TKR 07-30-2025
- BPMC 07-31-2025
- Dividend Yield
- TKR 1.82%
- BPMC N/A
- EPS Growth
- TKR N/A
- BPMC N/A
- EPS
- TKR 4.64
- BPMC N/A
- Revenue
- TKR $4,523,000,000.00
- BPMC $562,121,000.00
- Revenue This Year
- TKR N/A
- BPMC $44.46
- Revenue Next Year
- TKR $3.42
- BPMC $32.78
- P/E Ratio
- TKR $16.56
- BPMC N/A
- Revenue Growth
- TKR N/A
- BPMC 99.19
- 52 Week Low
- TKR $56.20
- BPMC $73.04
- 52 Week High
- TKR $90.49
- BPMC $128.52
- Technical
- Relative Strength Index (RSI)
- TKR 67.46
- BPMC 74.29
- Support Level
- TKR $72.16
- BPMC $128.06
- Resistance Level
- TKR $77.18
- BPMC $128.52
- Average True Range (ATR)
- TKR 1.79
- BPMC 0.29
- MACD
- TKR 0.36
- BPMC -1.18
- Stochastic Oscillator
- TKR 94.95
- BPMC 51.88
About TKR Timken Company (The)
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.